DNL126

· Denali Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DNL126, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A) [Phase 1, Phase 2]

See pricing